Pasar al contenido principal

Computer modeling of protein aggregation and function

IJC2020-045506-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Juan de la Cierva Incorporación
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

A Protein Misfolding Shaking Amplificationbased method for the spontaneous generation of hundreds of bona fide prions

  • Eraña, Hasier
  • Sampedro-Torres-Quevedo, Cristina
  • Charco, Jorge M.
  • Díaz-Domínguez, Carlos M.
  • Peccati, Francesca
  • San-Juan-Ansoleaga, Maitena
  • Vidal, Enric
  • Gonçalves-Anjo, Nuno
  • Pérez-Castro, Miguel A.
  • González-Miranda, Ezequiel
  • Piñeiro, Patricia
  • Fernández-Veiga, Leire
  • Galarza-Ahumada, Josu
  • Fernández-Muñoz, Eva
  • Perez de Nanclares, Guiomar
  • Telling, Glenn
  • Geijo, Mariví
  • Jiménez-Osés, Gonzalo
  • Castilla, Joaquín
Prion diseases are a group of rapidly progressing neurodegenerative disorders caused by the misfolding of the endogenous prion protein (PrPC) into a pathogenic form (PrPSc). This process, despite being the central event underlying these disorders, remains largely unknown at a molecular level, precluding the prediction of new potential outbreaks or interspecies transmission incidents. In this work, we present a method to generate bona fide recombinant prions de novo, allowing a comprehensive analysis of protein misfolding across a wide range of prion proteins from mammalian species. We study more than 380 different prion proteins from mammals and classify them according to their spontaneous misfolding propensity and their conformational variability. This study aims to address fundamental questions in the prion research field such as defining infectivity determinants, interspecies transmission barriers or the structural influence of specific amino acids and provide invaluable information for future diagnosis and therapy applications., The authors would like to thank the following for their support: IKERBasque foundation, personnel from vivarium, IT service (in particular to Sara Gómez Ramos for her assistance with the PrPdex webpage), maintenance departments of CIC bioGUNE, Neiker and IRTA-CReSA. The authors would also like to acknowledge the work from past laboratory members of the Prion Research Lab from CIC bioGUNE, that despite not directly involved in the manuscript have contributed along the years to the development of all the methods and techniques currently used in the laboratory (specially to Tomás Barrio and Leire Hervá for their efforts at the initial and end stages of the work, respectively). Finally, we would like to thank Jesús R. Requena for always useful scientific discussions and advice. The present work was partially funded by different grants awarded by “Ministerio de Economía y Competitividad” (Spanish Government), grant numbers PID2021-122201OB-C21, PID2021-1222010BC22, PID2021-125946OB-I00 and IJC2020-045506-I, funded by MCIN/ AEI /10.13039/501100011033 and co-financed by the European Regional Development Fund (ERDF), and by the Instituto de Salud Carlos III (ISCIII), grant number AC21_2/00024, to J.C. Additionally, CIC bioGUNE currently holds a Severo Ochoa Excellence accreditation, CEX2021- 001136-S, also funded by MCIN/AEI /10.13039/501100011033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Conformationally Restricted β-Sheet Breaker Peptides Incorporating Cyclic α-Methylisoserine Sulfamidates

  • Mazo, Nuria
  • Navo, Claudio D.
  • Peccati, Francesca
  • Andreo, Jacopo
  • Airoldi, Cristina
  • Goldsztejn, Gildas
  • Çarçabal, Pierre
  • Usabiaga, Imanol
  • Sodupe, Mariona
  • Wuttke, Stefan
  • Busto, Jesús H.
  • Peregrina, Jesús M.
  • Cocinero, Emilio J.
  • Jiménez-Osés, Gonzalo
Peptides containing variations of the β-amyloid hydrophobic core and five-membered sulfamidates derived from β-amino acid α-methylisoserine have been synthesized and fully characterized in the gas phase, solid state and in aqueous solution by a combination of experimental and computational techniques. The cyclic sulfamidate group effectively locks the secondary structure at the N-terminus of such hybrid peptides imposing a conformational restriction and stabilizing non-extended structures. This conformational bias, which is maintained in the gas phase, solid state and aqueous solution, is shown to be resistant to structure templating through assays of in vitro β-amyloid aggregation, acting as β-sheet breaker peptides with moderate activity., This work was funded by the Agencia Estatal de Investigación of Spain (AEI; grants CTQ2017-89132-P to M. S., RTI2018-099592-B-C21 to J. H. B., CTQ2017-89150-R to E.C. and RTI2018-099592-B-C22 to G. J. O. and the Severo Ochoa Excellence Accreditation (SEV-2016-0644 to CIC bioGUNE), the Italian Ministry of University and Research (MIUR; grant FABBR-MIUR 2018 to C. A.), the Basque Government (grants IT1162-19 and PIBA 2018-11 to E. C.) and Universidad del País Vasco (UPV/EHU; grants PPG17/10 and GIU18/207 to E. C.), CSIC (PIC2018, LINKA20249). F.P. thanks the Ministerio de Economía y Competitividad for a Juan de la Cierva Incorporación (IJC2020-045506-I) research contract., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Protein Misfolding Shaking Amplificationbased method for the spontaneous generation of hundreds of bona fide prions

  • Eraña, Hasier
  • Sampedro-Torres-Quevedo, Cristina
  • Charco, Jorge M.
  • Díaz-Domínguez, Carlos M.
  • Peccati, Francesca
  • San-Juan-Ansoleaga, Maitena
  • Vidal, Enric
  • Gonçalves-Anjo, Nuno
  • Pérez-Castro, Miguel A.
  • González-Miranda, Ezequiel
  • Piñeiro, Patricia
  • Fernández-Veiga, Leire
  • Galarza-Ahumada, Josu
  • Fernández-Muñoz, Eva
  • Perez de Nanclares, Guiomar
  • Telling, Glenn
  • Geijo, Mariví
  • Jiménez-Osés, Gonzalo
  • Castilla, Joaquín
Prion diseases are a group of rapidly progressing neurodegenerative disorders caused by the misfolding of the endogenous prion protein (PrPC) into a pathogenic form (PrPSc). This process, despite being the central event underlying these disorders, remains largely unknown at a molecular level, precluding the prediction of new potential outbreaks or interspecies transmission incidents. In this work, we present a method to generate bona fide recombinant prions de novo, allowing a comprehensive analysis of protein misfolding across a wide range of prion proteins from mammalian species. We study more than 380 different prion proteins from mammals and classify them according to their spontaneous misfolding propensity and their conformational variability. This study aims to address fundamental questions in the prion research field such as defining infectivity determinants, interspecies transmission barriers or the structural influence of specific amino acids and provide invaluable information for future diagnosis and therapy applications., The authors would like to thank the following for their support: IKERBasque foundation, personnel from vivarium, IT service (in particular to Sara Gómez Ramos for her assistance with the PrPdex webpage), maintenance departments of CIC bioGUNE, Neiker and IRTA-CReSA. The authors would also like to acknowledge the work from past laboratory members of the Prion Research Lab from CIC bioGUNE, that despite not directly involved in the manuscript have contributed along the years to the development of all the methods and techniques currently used in the laboratory (specially to Tomás Barrio and Leire Hervá for their efforts at the initial and end stages of the work, respectively). Finally, we would like to thank Jesús R. Requena for always useful scientific discussions and advice. The present work was partially funded by different grants awarded by “Ministerio de Economía y Competitividad” (Spanish Government), grant numbers PID2021-122201OB-C21, PID2021-1222010BC22, PID2021-125946OB-I00 and IJC2020-045506-I, funded by MCIN/ AEI /10.13039/501100011033 and co-financed by the European Regional Development Fund (ERDF), and by the Instituto de Salud Carlos III (ISCIII), grant number AC21_2/00024, to J.C. Additionally, CIC bioGUNE currently holds a Severo Ochoa Excellence accreditation, CEX2021- 001136-S, also funded by MCIN/AEI /10.13039/501100011033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Protein Misfolding Shaking Amplification-based method for the spontaneous generation of hundreds of bona fide prions

  • Eraña, Hasier|||0000-0001-8776-4211
  • Sampedro-Torres-Quevedo, Cristina|||0000-0001-6374-1760
  • Charco, Jorge M.|||0000-0003-3476-1855
  • Díaz-Domínguez, Carlos M.|||0000-0002-0410-1963
  • Peccati, Francesca|||0000-0002-7813-8216
  • San-Juan-Ansoleaga, Maitena|||0000-0001-7968-510X
  • Vidal Barba, Enric|||0000-0002-4965-3286
  • Gonçalves-Anjo, Nuno|||0000-0003-0586-2550
  • Pérez-Castro, Miguel A.|||0000-0003-2850-3470
  • González-Miranda, Ezequiel
  • Piñeiro, Patricia|||0000-0002-0062-2542
  • Fernández-Veiga, Leire
  • Galarza-Ahumada, Josu|||0000-0003-0275-559X
  • Fernández-Muñoz, Eva
  • Pérez de Nanclares, Guiomar|||0000-0002-2424-5294
  • Telling, Glenn
  • Geijo, Maria V.|||0000-0002-3120-1038
  • Jiménez-Osés, Gonzalo|||0000-0003-0105-4337
  • Castilla, Joaquín|||0000-0002-2216-1361
Prion diseases are a group of rapidly progressing neurodegenerative disorders caused by the misfolding of the endogenous prion protein (PrP C) into a pathogenic form (PrP Sc). This process, despite being the central event underlying these disorders, remains largely unknown at a molecular level, precluding the prediction of new potential outbreaks or interspecies transmission incidents. In this work, we present a method to generate bona fide recombinant prions de novo, allowing a comprehensive analysis of protein misfolding across a wide range of prion proteins from mammalian species. We study more than 380 different prion proteins from mammals and classify them according to their spontaneous misfolding propensity and their conformational variability. This study aims to address fundamental questions in the prion research field such as defining infectivity determinants, interspecies transmission barriers or the structural influence of specific amino acids and provide invaluable information for future diagnosis and therapy applications. To study neurodegenerative prion diseases, a method (PMSA) for generating prions spontaneously is presented. Applied to 380+ different prion proteins, their tendency to become pathogenic was ranked, illuminating their formation process.